Global Vial and Prefilled Syringe Market Size By Type (Glass Vial and Prefilled Syringe, Polymer Vial and Prefilled Syringe), By Application (Antithrombotics, Vaccines), By Region, And Segment Forecas...

The Global Vial and Prefilled Syringe Market was valued at USD 12.1 billion in 2023 and is expected to surpass USD 21.4 billion by 2031, growing at a CAGR of 7.3% during the forecast period from 2023 to 2031. The growth of the market is driven by the rising demand for injectable drugs, the growing adoption of self-injection devices, and increasing vaccine deployment. Prefilled syringes offer enhanced safety, convenience, and dosing accuracy, which is fueling their preference over traditional vials. Meanwhile, vials continue to be indispensable for multi-dose medications, especially in hospital settings and large-scale vaccination drives.

Drivers:

Rising Adoption of Biologics and Injectable Drugs:

The increasing number of biologics in development and commercialization has led to a higher demand for advanced drug delivery systems like prefilled syringes and vials, which ensure stability and sterility of complex formulations.

Growth in Self-Administration and Home Healthcare:

Patients increasingly prefer self-administration for chronic conditions such as diabetes and rheumatoid arthritis. Prefilled syringes facilitate this trend by providing ease of use, accurate dosing, and enhanced safety.

Expansion of Vaccination Programs:

Global immunization initiatives, including mass COVID-19 and influenza vaccination campaigns, have driven strong demand for both vials and prefilled syringes. Governments and healthcare institutions are investing in advanced packaging systems to improve vaccine distribution efficiency.

Restraints:

High Cost of Prefilled Syringes Compared to Vials:

While prefilled syringes offer numerous advantages, their manufacturing and filling processes are cost-intensive. This pricing barrier can limit adoption, especially in cost-sensitive healthcare markets.

Stringent Regulatory and Compliance Requirements:

The production and approval processes for injectable packaging solutions are highly regulated. Any deviation in material quality, sterility, or design can delay product launches and increase compliance costs.

Opportunity:

Technological Advancements in Manufacturing and Materials:

The development of high-barrier polymers, low-friction coatings, and innovative fill-finish technologies is opening new opportunities for product differentiation in the vial and prefilled syringe market.

Rising Demand in Emerging Markets:

Countries in Asia-Pacific, Latin America, and the Middle East are witnessing expanding healthcare infrastructure and rising awareness of injectable therapies. This is expected to drive strong growth in these regions for both vials and prefilled syringes.

Market by System Type Insights:

By system type, the Prefilled Syringes segment accounted for the largest market share in 2023. This dominance is attributed to their superior convenience, reduced drug wastage, and minimal risk of contamination. The segment is expected to continue its upward trajectory as demand for biologics and chronic disease management grows.

Conversely, the Vials segment continues to play a vital role, particularly in institutional settings where multi-dose packaging remains economical and practical for bulk drug administration.

Market by End-use Insights:

Based on end-use, the Hospital segment emerged as the largest revenue contributor in 2023. Hospitals prefer vials and prefilled syringes due to their sterility, ease of storage, and compatibility with standard injection protocols. Meanwhile, the Homecare segment is projected to experience the highest growth rate owing to the expanding trend of self-administration supported by innovations in user-friendly prefilled syringes.

Market by Regional Insights:

In terms of geography, North America dominated the global market in 2023, backed by advanced healthcare infrastructure, high biologics consumption, and strong adoption of home-based care solutions. However, Asia-Pacific is anticipated to register the fastest growth through 2031, driven by growing pharmaceutical production, vaccine programs, and healthcare reforms in countries like China and India.

Competitive Scenario:

Key players operating in the global vial and prefilled syringe market include BD (Becton, Dickinson and Company), Gerresheimer AG, SCHOTT AG, West Pharmaceutical Services, Inc., Nipro Corporation, Catalent, Inc., Baxter International Inc., Weigao Group, AptarGroup, and Terumo Corporation.

These companies are focusing on strategic partnerships, facility expansions, and innovation in container-closure systems to enhance their market positioning. For example:

In 2024, BD announced the expansion of its manufacturing plant in Nebraska to meet rising demand for prefilled syringes.

Gerresheimer launched a new lightweight vial design in 2023 aimed at improving transport and sustainability.

In 2025, West Pharmaceutical Services introduced a new line of ready-to-use vials integrated with tamper-evident closures.

Scope of Work – Global Vial and Prefilled Syringe Market

Report Metric Details

Market Size (2023) USD 12.1 billion

Projected Market Size (2031) USD 21.4 billion

CAGR (2023–2031) 7.3%

Market Segments By System Type (Vials, Prefilled Syringes), By End-use, By Region

Growth Drivers Biologics demand, self-injection trend, expanding vaccine use

Opportunities Tech innovation, emerging market demand

Key Market Developments:

2023: BD partnered with a major pharmaceutical company to develop dual-chamber prefilled syringes for lyophilized biologics.

2024: Gerresheimer AG introduced a new shatter-resistant polymer vial suitable for vaccines in extreme environments.

2025: Catalent expan